Dezhan HealthCare Co Ltd Total Assets
Dezhan HealthCare Co Ltd total assets. Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) holds total assets worth CN¥4.77 Billion CNY (≈ $697.93 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 000813 market cap for the company's overall valuation and market capitalisation.
Total Assets of Dezhan HealthCare Co Ltd (1995–2025)
Total assets of Dezhan HealthCare Co Ltd from 1995 to 2025. This chart illustrates how Dezhan HealthCare Co Ltd's total assets have evolved over time, based on quarterly financial data. See Dezhan HealthCare Co Ltd (000813) stock price for real-time trading data and today's change.
Dezhan HealthCare Co Ltd - Asset Composition Analysis
Dezhan HealthCare Co Ltd Total Assets Breakdown (December 2025)
Dezhan HealthCare Co Ltd total assets breakdown as of December 2025. Dezhan HealthCare Co Ltd's total assets of CN¥4.77 Billion consist of 52.7% current assets and 47.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 37.1% |
| Accounts Receivable | CN¥234.33 Million | 4.8% |
| Inventory | CN¥147.57 Million | 3.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥153.29 Million | 3.2% |
| Goodwill | CN¥244.89 Million | 5.0% |
Asset Composition Trend (1995–2025)
This chart illustrates how Dezhan HealthCare Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 000813 working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dezhan HealthCare Co Ltd's current assets represent 52.7% of total assets in 2025, a decrease from 69.4% in 1995.
- Cash Position: Cash and equivalents constituted 37.1% of total assets in 2025, up from 7.4% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is goodwill at 5.0% of total assets.
Dezhan HealthCare Co Ltd Competitors by Total Assets
Key competitors of Dezhan HealthCare Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Dezhan HealthCare Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.90 | 34.79 | 9.46 |
| Quick Ratio | 14.86 | 32.57 | 8.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.99 Billion | CN¥3.15 Billion | CN¥3.19 Billion |
Dezhan HealthCare Co Ltd - Advanced Valuation Insights
This section examines the relationship between Dezhan HealthCare Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.55 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | CN¥4.87 Billion |
| Market Capitalization | $917.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dezhan HealthCare Co Ltd's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dezhan HealthCare Co Ltd's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dezhan HealthCare Co Ltd (1995–2025)
The table below shows the annual total assets of Dezhan HealthCare Co Ltd from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.87 Billion ≈ $712.93 Million |
-8.42% |
| 2024-12-31 | CN¥5.32 Billion ≈ $778.46 Million |
-1.09% |
| 2023-12-31 | CN¥5.38 Billion ≈ $787.06 Million |
-5.21% |
| 2022-12-31 | CN¥5.67 Billion ≈ $830.34 Million |
-1.79% |
| 2021-12-31 | CN¥5.78 Billion ≈ $845.51 Million |
-9.71% |
| 2020-12-31 | CN¥6.40 Billion ≈ $936.44 Million |
+7.96% |
| 2019-12-31 | CN¥5.93 Billion ≈ $867.42 Million |
+0.10% |
| 2018-12-31 | CN¥5.92 Billion ≈ $866.52 Million |
+15.23% |
| 2017-12-31 | CN¥5.14 Billion ≈ $751.99 Million |
+30.86% |
| 2016-12-31 | CN¥3.93 Billion ≈ $574.63 Million |
+99.11% |
| 2015-12-31 | CN¥1.97 Billion ≈ $288.60 Million |
-2.93% |
| 2014-12-31 | CN¥2.03 Billion ≈ $297.31 Million |
+6.90% |
| 2013-12-31 | CN¥1.90 Billion ≈ $278.10 Million |
+219.56% |
| 2012-12-31 | CN¥594.73 Million ≈ $87.03 Million |
-11.08% |
| 2011-12-31 | CN¥668.82 Million ≈ $97.87 Million |
+4.62% |
| 2010-12-31 | CN¥639.31 Million ≈ $93.55 Million |
+23.83% |
| 2009-12-31 | CN¥516.28 Million ≈ $75.55 Million |
-4.70% |
| 2008-12-31 | CN¥541.74 Million ≈ $79.27 Million |
-8.33% |
| 2007-12-31 | CN¥590.94 Million ≈ $86.47 Million |
+2.23% |
| 2006-12-31 | CN¥578.04 Million ≈ $84.59 Million |
-3.23% |
| 2005-12-31 | CN¥597.31 Million ≈ $87.41 Million |
-17.93% |
| 2004-12-31 | CN¥727.81 Million ≈ $106.50 Million |
-31.04% |
| 2003-12-31 | CN¥1.06 Billion ≈ $154.45 Million |
-13.78% |
| 2002-12-31 | CN¥1.22 Billion ≈ $179.14 Million |
+0.58% |
| 2001-12-31 | CN¥1.22 Billion ≈ $178.11 Million |
-10.33% |
| 2000-12-31 | CN¥1.36 Billion ≈ $198.62 Million |
+18.47% |
| 1999-12-31 | CN¥1.15 Billion ≈ $167.66 Million |
+1.55% |
| 1998-12-31 | CN¥1.13 Billion ≈ $165.10 Million |
+3.77% |
| 1997-12-31 | CN¥1.09 Billion ≈ $159.10 Million |
+13.67% |
| 1996-12-31 | CN¥956.52 Million ≈ $139.97 Million |
+1.19% |
| 1995-12-31 | CN¥945.30 Million ≈ $138.33 Million |
-- |
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including fam… Read more